1型糖尿病中朊蛋白PrPC的细胞定位、表达改变及非常规蛋白转运
本研究分析非糖尿病、1型糖尿病及自身抗体阳性器官供者胰腺,发现PrPC在胰岛β细胞表达,且在糖尿病胰岛素阴性胰岛的α细胞中异常激活;PrPC定位于质膜和内质网而非高尔基体,提示非常规转运;PRNP和STIP1基因表达在1型糖尿病及自身抗体阳性胰腺中显著改变。
要点
- PrPC在非糖尿病和1型糖尿病胰岛β细胞中表达,但在糖尿病胰岛素阴性胰岛的α细胞中异常激活。
- PrPC定位于质膜和内质网,不经过高尔基体,提示非常规蛋白转运机制。
- PRNP和STIP1基因表达在1型糖尿病及自身抗体阳性胰腺中显著改变。
核心结论
- PrPC在1型糖尿病胰腺中定位和表达改变,并与NCAM1和STI1共定位,提示其可能参与1型糖尿病发病。
研究设计与样本
- 免疫荧光分析12例非糖尿病、12例1型糖尿病和12例自身抗体阳性供者胰腺组织。
- 从29例非糖尿病、29例1型糖尿病和24例自身抗体阳性供者胰腺分离总RNA评估PrPC表达。
- 对非糖尿病和1型糖尿病供者胰腺总蛋白进行PrPC特异性免疫印迹分析。
主要发现
- 在非糖尿病和1型糖尿病胰岛中,PrPC与β细胞共定位;在糖尿病胰岛素阴性胰岛中,PrPC在α细胞中意外激活。
- PrPC定位于质膜和内质网,但不位于高尔基体,定义了两个细胞池和绕过高尔基体的非常规蛋白转运机制。
- PrPC分别与NCAM1和STI1在质膜和内质网共定位,提示其功能与细胞保护、信号传导、分化和形态发生相关。
- PRNP和STIP1基因表达在1型糖尿病和自身抗体阳性胰腺中均显著改变。
临床怎么用
- PrPC在1型糖尿病胰岛α细胞中的异常激活及非常规转运机制可能为理解1型糖尿病发病提供新视角。
- PrPC与NCAM1和STI1的相互作用提示其可能通过细胞保护和信号传导通路影响胰岛细胞功能。
局限性
- 研究为描述性观察,样本量有限,未进行功能验证。
- PrPC在1型糖尿病发病中的具体机制尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Normal cellular prion protein (PrPC) is a conserved mammalian glycoprotein found on the outer plasma membrane leaflet through a glycophosphatidylinositol anchor. Although PrPC is expressed by a wide range of tissues throughout the body, the complete repertoire of its functions has not been fully determined. The misfolded pathogenic isoform PrPSc (the scrapie form of PrP) is a causative agent of neurodegenerative prion diseases. The aim of this study is to evaluate PrPC localisation, expression and trafficking in pancreases from organ donors with and without type 1 diabetes and to infer PrPC function through studies on interacting protein partners. METHODS: In order to evaluate localisation and trafficking of PrPC in the human pancreas, 12 non-diabetic, 12 type 1 diabetic and 12 autoantibody-positive organ donor tissue samples were analysed using immunofluorescence analysis. Furthermore, total RNA was isolated from 29 non-diabetic, 29 type 1 diabetic and 24 autoantibody-positive donors to estimate PrPC expression in the human pancreas. Additionally, we performed PrPC-specific immunoblot analysis on total pancreatic protein from non-diabetic and type 1 diabetic organ donors to test whether changes in PrPC mRNA levels leads to a concomitant increase in PrPC protein levels in human pancreases. RESULTS: In non-diabetic and type 1 diabetic pancreases (the latter displaying both insulin-positive [INS(+)] and -negative [INS(-)] islets), we found PrPC in islets co-registering with beta cells in all INS(+) islets and, strikingly, unexpected activation of PrPC in alpha cells within diabetic INS(-) islets. We found PrPC localised to the plasma membrane and endoplasmic reticulum (ER) but not the Golgi, defining two cellular pools and an unconventional protein trafficking mechanism bypassing the Golgi. We demonstrate PrPC co-registration with established protein partners, neural cell adhesion molecule 1 (NCAM1) and stress-inducible phosphoprotein 1 (STI1; encoded by STIP1) on the plasma membrane and ER, respectively, linking PrPC function with cyto-protection, signalling, differentiation and morphogenesis. We demonstrate that both PRNP (encoding PrPC) and STIP1 gene expression are dramatically altered in type 1 diabetic and autoantibody-positive pancreases. CONCLUSIONS/INTERPRETATION: As the first study to address PrPC expression in non-diabetic and type 1 diabetic human pancreas, we provide new insights for PrPC in the pathogenesis of type 1 diabetes. We evaluated the cell-type specific expression of PrPC in the human pancreas and discovered possible connections with potential interacting proteins that we speculate might address mechanisms relevant to the role of PrPC in the human pancreas.
引用
- Hiller H, Yang C, Beachy DE, et al. Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrPC, in type 1 diabetes. Diabetologia. 2021. PMID: 34274990. doi:10.1007/s00125-021-05501-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。